|
EP3395332A1
|
|
Hormone softgel capsules and a process for the preparation thereof
|
|
CA2994781A1
|
|
A process for the preparation of the compound n-(3,5-dimethylphenyl)-n'-(2-trifluoromethylphenyl) guanidine
|
|
EP3272333A1
|
|
Vaginal composition comprising a combination of estrogen and vitamin d
|
|
WO2015056164A1
|
|
1,4-cyclohexylamine derivatives and processes for the preparation thereof
|
|
WO2015018800A1
|
|
Inhalable particles comprising tiotropium and indacaterol
|
|
WO2014154908A1
|
|
Selective alkylation of cyclopentyl alcohols
|
|
EP2781509A1
|
|
New polymorph of ivabradine hydrochloride and method for its preparation
|
|
EP2781214A1
|
|
Formulation of amorphous calcium L-5-methyltetrahydrofolate (L-5-MTHF-Ca)
|
|
TW201332585A
|
|
Core sheath drug delivery devices
|
